↓ Skip to main content

Comparative clinical efficacy and safety of the proposed biosimilar ABP 710 with infliximab reference product in patients with rheumatoid arthritis

Overview of attention for article published in Arthritis Research & Therapy, March 2020
Altmetric Badge

Citations

dimensions_citation
14 Dimensions

Readers on

mendeley
40 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Comparative clinical efficacy and safety of the proposed biosimilar ABP 710 with infliximab reference product in patients with rheumatoid arthritis
Published in
Arthritis Research & Therapy, March 2020
DOI 10.1186/s13075-020-2142-1
Pubmed ID
Authors

Mark C. Genovese, Juan Sanchez-Burson, MyungShin Oh, Eva Balazs, Jeffrey Neal, Andrea Everding, Tomas Hala, Rafal Wojciechowski, Gary Fanjiang, Stanley Cohen

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 40 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 40 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 6 15%
Other 4 10%
Researcher 3 8%
Student > Bachelor 2 5%
Professor 2 5%
Other 3 8%
Unknown 20 50%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 8 20%
Medicine and Dentistry 7 18%
Nursing and Health Professions 2 5%
Chemical Engineering 1 3%
Biochemistry, Genetics and Molecular Biology 1 3%
Other 0 0%
Unknown 21 53%